CompoAtlas

DAWN BRIDGE TRIDIZEST POWDER

DAWN BRIDGE TRIDIZEST POWDER : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
ALPHA-GALACTOSIDASEALPHA-GALACTOSIDASE[16.68 mg,2000 mg]Alpha-galactosidase
AMYLASEAMYLASE[50 mg,2000 mg]Amylase
BROMELAINBROMELAIN[0.28 mg,2000 mg]Not identified
CELLULASECELLULASE[2.68 mg,2000 mg]Cellulase
GLUCOAMYLASEGLUCOAMYLASE[15.24 mg,2000 mg]Glucoamylase
INVERTASEINVERTASE[4.44 mg,2000 mg]Invertase
LACTASELACTASE[35 mg,2000 mg]Lactase
LIPASELIPASE[5.32 mg,2000 mg]Lipase
PROTEASEPROTEASE[25 mg,2000 mg]Protéase
PROTEASEPROTEASE[65 mg,2000 mg]Protéase
PROTEASEPROTEASE[7.68 mg,2000 mg]Protéase
FRUCTOOLIGOSACCHARIDESFRUCTOOLIGOSACCHARIDES[100 mg,2000 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL26076118N
Type
Health supplement
Published status
PRODUCT APPROVED
Licence holder
OMEGA HEALTH PRODUCTS SDN BHD
Manufacturer
OMEGA HEALTH PRODUCTS SDN BHD
Registration period starting
2026-07-07
Published validity end
2031-07-07

Original register data

View published fields and their variants
Active ingredients
ALPHA-GALACTOSIDASE[16.68 mg,2000 mg],AMYLASE[50 mg,2000 mg],BROMELAIN[0.28 mg,2000 mg],CELLULASE[2.68 mg,2000 mg],GLUCOAMYLASE[15.24 mg,2000 mg],INVERTASE[4.44 mg,2000 mg],LACTASE[35 mg,2000 mg],LIPASE[5.32 mg,2000 mg],PROTEASE[25 mg,2000 mg],PROTEASE[65 mg,2000 mg],PROTEASE[7.68 mg,2000 mg],FRUCTOOLIGOSACCHARIDES[100 mg,2000 mg]
Valid until
2031-07-07
Registration date
2026-07-07
Published description
HEALTH SUPPLEMENT
Licence holder
OMEGA HEALTH PRODUCTS SDN BHD
Producer
OMEGA HEALTH PRODUCTS SDN BHD
Published name
DAWN BRIDGE TRIDIZEST POWDER
Published reference
2026012021159N
Registration number
MAL26076118N
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL26076118N

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “DAWN BRIDGE TRIDIZEST POWDER”, https://compoatlas.com/en/supplements/malaysia/MAL26076118N-dawn-bridge-tridizest-powder, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line